Using Extended Release Buprenorphine Injection to Discontinue Sublingual Buprenorphine: A Case Series.
Ritvo AD, Calcaterra SL, Ritvo JI.
J Addict Med · journal article; research support, n.i.h., extramural · DOI 10.1097/adm.0000000000000738 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för buprenorphine. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
11 träffarMicroinduction of Buprenorphine/Naloxone: A Review of the Literature.
Ahmed S, Bhivandkar S, Lonergan BB, Suzuki J.
Am J Addict · review; journal article; research support, n.i.h., extramural · DOI 10.1111/ajad.13135Buprenorphine for opioid dependence.
Ling W.
Expert Rev Neurother · historical article; research-article; journal article · DOI 10.1586/ern.09.26Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.
Rennison D, Neal AP, Cami-Kobeci G, Aceto MD, Martinez-Bermejo F, Lewis JW, Husbands SM.
J Med Chem · research-article; journal article; research support, n.i.h., extramural · DOI 10.1021/jm070255oA highly selective kappa-opioid receptor agonist with low addictive potential and dependence liability.
Park HS, Lee HY, Kim YH, Park JK, Zvartau EE, Lee H.
Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2006.02.017Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
Yu S, Zhang X, Sun Y, Peng Y, Johnson J, Mandrell T, Shukla AJ, Laizure SC.
J Am Assoc Lab Anim Sci · research support, non-u.s. gov't; journal articleBuprenorphine: considerations for pain management.
Johnson RE, Fudala PJ, Payne R.
J Pain Symptom Manage · research support, non-u.s. gov't; review; journal article · DOI 10.1016/j.jpainsymman.2004.07.005Buprenorphine: a unique drug with complex pharmacology.
Lutfy K, Cowan A.
Curr Neuropharmacol · research-article; journal article · DOI 10.2174/1570159043359477Medicines and the drug control treaties: is buprenorphine for opioid addiction at risk of being lost?
Costa E Silva JA.
Hum Psychopharmacol · historical article; research support, non-u.s. gov't; review; journal article · DOI 10.1002/hup.588Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist.
Huang P, Kehner GB, Cowan A, Liu-Chen LY.
J Pharmacol Exp Ther · comparative study; research support, u.s. gov't, p.h.s.; journal article · DOI 10.1016/s0022-3565(24)29586-0Structural determinants of efficacy for kappa opioid receptors in the orvinol series: 7,7-spiro analogues of buprenorphine.
Husbands SM, Lewis JW.
J Med Chem · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1021/jm991165p